Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Hong

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
ACS Applied Materials & Interfaces|April 24, 2025
A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection <i>In Vitro</i> and <i>In Vivo</i>Ling Zhong, Wanlin Zhang, Rui Xiao, et al.
NPJ Vaccines|April 1, 2024
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccineXiaohua Ye, David J H Shih, Zhiqiang Ku, et al.
Viruses|November 27, 2021
Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) DosesHaiwen Chen, Ling Zhong, Wanlin Zhang, et al.
Antibody Therapeutics|April 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugatesAiko Yamaguchi, Junping Hong, Leike Li, et al.
ACS Nano|January 11, 2023
Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay BoostingFajun Li, Junping Hong, Chaoheng Guan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2026
Spike destabilization attenuates Mink Cluster 5 SARS-CoV-2Julia N Faraone, Pei Li, Junping Hong, et al.
Emerging Microbes & Infections|August 5, 2023
Neutralizing antibodies against EBV gp42 show potent <i>in vivo</i> protection and define novel epitopesQian Wu, Ling Zhong, Dongmei Wei, et al.
Journal of Virology|March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Vaccine|October 17, 2022
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylationTingting Deng, Tingting Li, Gege Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 27, 2023
The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumorsGuosong Wang, Jiali Cao, Mengxuan Gui, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
ACS Applied Materials & Interfaces|April 24, 2025
A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection <i>In Vitro</i> and <i>In Vivo</i>Ling Zhong, Wanlin Zhang, Rui Xiao, et al.
NPJ Vaccines|April 1, 2024
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccineXiaohua Ye, David J H Shih, Zhiqiang Ku, et al.
Viruses|November 27, 2021
Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) DosesHaiwen Chen, Ling Zhong, Wanlin Zhang, et al.
Antibody Therapeutics|April 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugatesAiko Yamaguchi, Junping Hong, Leike Li, et al.
ACS Nano|January 11, 2023
Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay BoostingFajun Li, Junping Hong, Chaoheng Guan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2026
Spike destabilization attenuates Mink Cluster 5 SARS-CoV-2Julia N Faraone, Pei Li, Junping Hong, et al.
Emerging Microbes & Infections|August 5, 2023
Neutralizing antibodies against EBV gp42 show potent <i>in vivo</i> protection and define novel epitopesQian Wu, Ling Zhong, Dongmei Wei, et al.
Journal of Virology|March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Vaccine|October 17, 2022
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylationTingting Deng, Tingting Li, Gege Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 27, 2023
The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumorsGuosong Wang, Jiali Cao, Mengxuan Gui, et al.
Pageof 3